These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

351 related items for PubMed ID: 3471089

  • 41. Antibiotic review: the experience of one pharmacy and therapeutics committee.
    Kiepert DR.
    QRB Qual Rev Bull; 1979 Jan; 5(1):24-7. PubMed ID: 121376
    [No Abstract] [Full Text] [Related]

  • 42. Developing a drug usage evaluation program.
    Thornton J.
    Hosp Formul; 1991 Dec; 26(12):971-2. PubMed ID: 10115411
    [Abstract] [Full Text] [Related]

  • 43. Strategies for deleting popular drugs from a hospital formulary.
    Lemay AP, Salzer LB, Visconti JA, Latiolais CJ.
    Am J Hosp Pharm; 1981 Apr; 38(4):506-10. PubMed ID: 7282675
    [Abstract] [Full Text] [Related]

  • 44. P & T Committee role in advocating rational therapeutics.
    Borreson R.
    Hosp Formul; 1986 May; 21(5):590-8. PubMed ID: 10311625
    [Abstract] [Full Text] [Related]

  • 45. Developing a successful strategy for controlling inappropriate antibiotic use and cost.
    Mu-Chow KJ, Rich DS.
    Top Hosp Pharm Manage; 1988 Aug; 8(2):1-21. PubMed ID: 10314291
    [No Abstract] [Full Text] [Related]

  • 46. Adverse drug reaction reporting system: developing a well-monitored program.
    Kilarski DJ, Ziegler B, Coarse J, Buchanan C.
    Hosp Formul; 1986 Sep; 21(9):949-52. PubMed ID: 10289704
    [Abstract] [Full Text] [Related]

  • 47. P & T Committee perspectives: maintaining a successful formulary system in a private community hospital.
    Benner EJ, Mykita L, Brown K.
    Hosp Formul; 1990 Apr; 25(4):423-6, 428, 430. PubMed ID: 10104233
    [Abstract] [Full Text] [Related]

  • 48. Organization and operation of P & T Committees in the state of Florida: a survey.
    Hatton RC, Doering PL.
    Hosp Formul; 1990 Sep; 25(9):983-6, 988-9. PubMed ID: 10106259
    [Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. Achieving rational therapeutics through consensus-based protocols and follow-up.
    Quintiliani R, Gousse GC, Chow MS.
    Hosp Formul; 1990 Mar; 25(3):283-4, 289-94. PubMed ID: 10103836
    [Abstract] [Full Text] [Related]

  • 51. How to develop a proactive formulary system.
    Crane VS, Gonzalez ER, Hull BL.
    Hosp Formul; 1994 Oct; 29(10):700-2, 704-8, 710. PubMed ID: 10137847
    [Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. Pharmacy-coordinated process for evaluating physician drug prescribing.
    Peterson CD, Goldberg DE.
    Am J Hosp Pharm; 1989 Sep; 46(9):1787-91. PubMed ID: 2508469
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. An aminoglycoside monitoring service in a community hospital using a microcomputer.
    Voytovich RM, Outten RL.
    Hosp Pharm; 1987 Mar; 22(3):267-72. PubMed ID: 10281372
    [Abstract] [Full Text] [Related]

  • 60. P&T Committee antibiotic cost considerations.
    Rinehart JR.
    Hosp Formul; 1986 Aug; 21(8):857-9, 862-4. PubMed ID: 10277580
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.